PolarityTE to Report Fiscal Year 2021 Financial Results on March 30, 2022

Error message

Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

SALT LAKE CITY, March 10, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) today announced that it will report results for the year ended December 31, 2021, by press release on Wednesday, March 30, 2022, at approximately 7:30 a.m. Eastern Time.

Metadata

Provider:

PR Newswire

Retrieved on:

Thursday, March 10, 2022

Information

Tags:

International, BLA, PTE, Earnings call, SALT, Company, IND, Webcast, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Q&A, Skint Records, Food, Biotechnology, Pharmaceutical industry

Geotags:

UTAH, CANADA

Organisation:

POLARITYTE, INC.

Stock Symbol:

NASDAQ-NMS:PTE

Summary

Key Points:

SALT LAKE CITY, March 10, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) today announced that it will report results for the year ended December 31, 2021, by press release on Wednesday, March 30, 2022, at approximately 7:30 a.m. Eastern Time.
In addition, the Company will host a conference call and webcast with Q&A on March 30, 2022, at 8:30 a.m. Eastern Time.
The conference call can be accessed by calling 1-800-581-5838 (U.S. and Canada) or +44 (0)330 165 3641 (International) with confirmation code 361897 and referencing "PolarityTE Fiscal Year 2021 Earnings Call".
POLARITYTE, the POLARITYTE logo, SKINTE, and WHERE SELF REGENERATES SELF are registered trademarks of PolarityTE, Inc.

PolarityTE to Report Fiscal Year 2021 Financial Results on March 30, 2022

SALT LAKE CITY, March 10, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) today announced that it will report results for the year ended December 31, 2021, by press release on Wednesday, March 30, 2022, at approximately 7:30 a.m. Eastern Time.

In addition, the Company will host a conference call and webcast with Q&A on March 30, 2022, at 8:30 a.m. Eastern Time. The conference call can be accessed by calling 1-800-581-5838 (U.S. and Canada) or +44 (0)330 165 3641 (International) with confirmation code 361897 and referencing "PolarityTE Fiscal Year 2021 Earnings Call". A webcast of the conference call can be accessed by using the link below.

Earnings Call Webcast - CLICK HERE

A replay of the earnings conference call will be available for 30 days, beginning approximately one hour after the conclusion of the call and can be found by visiting PolarityTE's website at https://www.polarityte.com/news-media/events, or by clicking on the link above.

About PolarityTE®
PolarityTE, Inc., headquartered in Salt Lake City, Utah, is a biotechnology company developing regenerative tissue products. PolarityTE's first regenerative tissue product is SkinTE®. PolarityTE has an open investigational new drug application (IND) for SkinTE® with the U.S. Food and Drug Administration (FDA) and is now pursuing the first of two pivotal studies on SkinTE® needed to support a biologics license application (BLA) for a chronic cutaneous ulcer indication. SkinTE® is available for investigational use only. Learn more at www.PolarityTE.com.

POLARITYTE, the POLARITYTE logo, SKINTE, and WHERE SELF REGENERATES SELF are registered trademarks of PolarityTE, Inc.

CONTACTS

Investors:
PolarityTE Investor Relations
[email protected]
(385) 831-5284

Media:
David Schull or Ignacio Guerrero-Ros
[email protected]
[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/polarityte-to-report-fiscal-year-2021-financial-results-on-march-30-2022-301499532.html

SOURCE PolarityTE, Inc.